Oct 25, 2026 10:20AM

Oct 25, 2026 08:11AM

Oct 25, 2026 07:00AM

Oct 25, 2026 07:00AM

Oct 25, 2026 04:35AM

Oct 24, 2026 07:30PM

Oct 24, 2026 08:45AM Parabilis reports 72% response rate for desmoid tumor drug

Oct 24, 2026 04:15AM

Oct 24, 2026 04:15AM

Oct 24, 2026 02:30AM

Oct 24, 2026 02:30AM

Oct 23, 2026 04:38PM

Oct 23, 2026 04:06PM

Oct 23, 2026 04:04PM Climb Bio and Mabworks report Phase 1 data for IgAN antibody CLYM116

Oct 23, 2026 04:04PM

Oct 23, 2026 03:34PM

Oct 23, 2026 02:16PM

Oct 23, 2026 01:42PM

Oct 23, 2026 10:55AM

Oct 23, 2026 10:49AM

Oct 23, 2026 10:30AM Kyverna shares phase 1 data on miv-cel for progressive MS

Oct 23, 2026 10:16AM

Oct 23, 2026 10:16AM

Oct 23, 2026 10:16AM

Oct 23, 2026 09:15AM

Oct 23, 2026 09:00AM

Oct 23, 2026 08:30AM

Oct 23, 2026 08:30AM Lexicon's HCM trial enrolls 542 patients, exceeding 500 target

Oct 23, 2026 08:02AM

Oct 23, 2026 08:00AM

Oct 23, 2026 08:00AM

Oct 23, 2026 08:00AM

Oct 23, 2026 07:37AM

Oct 23, 2026 07:31AM

Oct 23, 2026 07:30AM Takeda's TAK-921 meets dual endpoints in gastric cancer trial

Oct 23, 2026 07:30AM

Oct 23, 2026 07:01AM

Oct 23, 2026 07:00AM

Oct 23, 2026 06:30AM

Oct 23, 2026 06:10AM

Oct 23, 2026 06:01AM

Oct 23, 2026 06:00AM IDEAYA's IDE849 shows early survival data in relapsed lung cancer

Oct 23, 2026 04:52AM

Oct 23, 2026 03:45AM

Oct 23, 2026 03:15AM

Oct 22, 2026 04:31PM

Oct 22, 2026 04:05PM

Oct 22, 2026 04:05PM

Oct 22, 2026 04:05PM RBC Capital Reiterates Sector Perform Rating on Merck (MRK)

Oct 22, 2026 02:59PM

335,221 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All